TickerFactsScreenerDevelopers

Amneal Pharmaceuticals, Inc. (AMRX) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2016: $115.06M2017: $234.19M2018: $250.23M2019: $1.71M2020: $379.00M2021: $241.82M2022: $65.10M2023: $345.58M2024: $295.10M2025: $339.99M$339.99M
2016Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025$339.99M+15.2%
2024$295.10M-14.6%
2023$345.58M+430.8%
2022$65.10M-73.1%
2021$241.82M-36.2%
2020$379.00M+22128.8%
2019$1.71M-99.3%
2018$250.23M+6.9%
2017$234.19M+103.5%
2016$115.06M—